海洋生物技术市场－全球产业规模、份额、趋势、机会和预测，按类型、按技术、按应用、按最终用户产业、按地区和竞争进行细分，2020-2030 年

2024年，全球海洋生物技术市场规模为63.5亿美元，预计2030年将达到95.7亿美元，预测期内复合年增长率为7.08%。全球海洋生物技术市场正在经历显着成长，这得益于对海藻相关产品等海洋天然产品的需求不断增长，以及对永续天然产品开发的投资不断增加。此外，渔业、药物研发和水产养殖领域的不断进步预计将在预测期内推动市场成长。

此外，预测期内，对各种高效疗法的需求不断增长，以提供高品质的医疗服务，将进一步推动海洋生物技术市场的发展。海洋衍生药物被开发用于治疗各种慢性疾病，例如心血管疾病、神经系统疾病。此外，消费者意识的增强以及对环保产品的日益重视，也进一步提升了对海洋生物技术的需求。

关键市场驱动因素

对永续生物基产品的需求不断增长

主要市场挑战

监管和法律框架的复杂性

主要市场趋势

扩大海洋衍生药物和营养保健品

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球海洋生物技术市场展望

• 市场规模和预测
  • 按价值
• 市场占有率和预测
  • 按类型（生物活性物质与生物材料）
  • 按技术分类（微生物分离和培养 vs. 不依赖培养的技术）
  • 按应用（水产养殖和食品、环境与人类健康、药物研发、其他）
  • 按最终用户行业（生物技术与製药、化学品、化妆品、其他）
  • 按地区
  • 按公司分类（2024）
• 市场地图
  • 按类型
  • 依技术
  • 按应用
  • 按最终用户产业
  • 按地区

第六章：北美海洋生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 北美：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲海洋生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 欧洲：国家分析
  • 法国
  • 德国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太海洋生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：南美洲海洋生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• 南美洲：国家分析
  • 巴西
  • 阿根廷
  • 哥伦比亚

第十章：中东和非洲海洋生物技术市场展望

• 市场规模和预测
• 市场占有率和预测
• MEA：国家分析
  • 南非
  • 沙乌地阿拉伯
  • 阿联酋

第 11 章：市场动态

• 驱动程式
• 挑战

第 12 章：市场趋势与发展

• 最新动态
• 併购
• 产品发布

第 13 章：海洋生物技术市场：SWOT 分析

第 14 章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的力量
• 顾客的力量
• 替代产品/服务的威胁

第 15 章：竞争格局

• Lonza Group
• Sea Run Holdings Inc
• PharmaMar SA
• Cyanotech Corporation
• New England Biolabs Inc.
• Qingdao Codo International Ltd
• Nutrex Hawai Inc.
• Royal DSM NV
• Prolume Ltd.
• CP Kelco US Inc.

第 16 章：策略建议

第17章调查会社について・免责事项

Global Marine Biotechnology Market was valued at USD 6.35 billion in 2024 and is expected to reach USD 9.57 billion by 2030 with a CAGR of 7.08% during the forecast period. The global market for Marine Biotechnology is experiencing significant growth, driven by growing demand for natural products from marine derived like seaweed related products and increasing investments in the development of sustainable and natural products. Additionally, increasing advancement in the areas of fisheries, drug discovery and aquaculture are expected to boost market growth in the forecast period.

Additionally, increasing demand for different efficient therapeutics to deliver quality care is further propel the marine biotechnology market in the forecast period. Marine derived drugs are developed for the treatment of different chronic diseases such as cardiovascular disease, neurological disorder. Besides, growing consumer awareness and increasing emphasis on eco-friendly products is further enhancing the demand of marine biotechnology.

Key Market Drivers

Growing Demand for Sustainable Bio-based Products

The increasing global emphasis on sustainability and environmentally friendly alternatives is a significant driver for the marine biotechnology market. Marine organisms provide a vast and largely untapped source of bioactive compounds, enzymes, and polymers, which are being increasingly utilized in pharmaceuticals, nutraceuticals, cosmetics, and industrial applications. These natural, biodegradable materials offer a viable alternative to petroleum-based products, aligning with global sustainability goals.

Government support for bio-based economies further fuels this demand. For instance, the European Union's Bioeconomy Strategy, revised in 2018, places strong emphasis on utilizing renewable biological resources sustainably, including marine resources. The EU Blue Bioeconomy Report highlights how marine biotechnology supports sustainable growth and the circular economy, with funding initiatives such as the Horizon Europe program allocating billions of euros toward marine bioeconomy research and innovation.

Additionally, the U.S. Department of Energy (DOE) has supported research into marine algae for biofuel production under its Bioenergy Technologies Office (BETO). BETO-funded programs such as the Algae Technology Education Consortium (ATEC) aim to develop the U.S. algae workforce and support bio-product development. Marine biotechnology is thus seen as pivotal to national strategies for climate change mitigation, resource security, and economic development.

The rise in consumer awareness about the environmental impact of synthetic chemicals and plastics is also driving demand for marine-derived alternatives. As industries continue to seek sustainable raw materials, marine biotechnology stands to benefit, making it a key component of the global transition to a greener economy.

Key Market Challenges

Regulatory and Legal Framework Complexities

One of the most pressing challenges in the global marine biotechnology market is navigating the complex and fragmented regulatory landscape governing access to marine genetic resources. Marine bioprospecting often involves sampling from international waters or exclusive economic zones (EEZs), leading to jurisdictional ambiguities and compliance issues under international law. The Nagoya Protocol on Access and Benefit-sharing (ABS) under the Convention on Biological Diversity (CBD) aims to regulate the use of genetic resources and ensure fair benefit-sharing. However, its implementation varies significantly across countries, causing uncertainty for marine biotech companies. For instance, some countries enforce strict ABS laws that require long and bureaucratic approval processes, while others have more lenient or unclear regulations.

Moreover, marine biotechnology activities often intersect with maritime laws, environmental protection regulations, and ethical concerns over the exploitation of marine biodiversity. This complexity can delay research, restrict access to biological samples, and hinder international collaboration. In areas beyond national jurisdiction (ABNJ), legal frameworks for access and benefit-sharing remain under negotiation under the UN Convention on the Law of the Sea (UNCLOS). Governments are working to address these gaps. The 2023 UN High Seas Treaty, adopted to protect biodiversity in ABNJ, aims to establish clearer rules for marine genetic resource usage. However, practical implementation will take time, and industry stakeholders still face regulatory uncertainty in the interim.

Key Market Trends

Expansion of Marine-Derived Pharmaceuticals and Nutraceuticals

The growing recognition of marine organisms as sources of novel bioactive compounds is reshaping the pharmaceutical and nutraceutical industries. Marine-derived compounds have shown promising therapeutic potential, particularly in areas such as anti-inflammatory, anticancer, antimicrobial, and neuroprotective treatments. This is driving increased investment in marine-based drug discovery and nutraceutical development.

Marine-derived drugs such as Ziconotide, developed from cone snail venom for chronic pain, and Trabectedin, derived from sea squirts for cancer treatment, have demonstrated the clinical and commercial viability of marine bioproducts. According to the U.S. Food and Drug Administration (FDA), multiple marine-origin compounds are in various stages of clinical trials, indicating the growing interest in marine pharmaceuticals. Governments are also increasingly promoting the exploration of marine biodiversity for medical applications. The European Marine Biological Resource Centre (EMBRC-ERIC), supported by the European Commission, facilitates access to marine biodiversity and research infrastructure to accelerate drug discovery. Similarly, India's Department of Biotechnology has launched the Marine Bioresource and Biotechnology (MBB) program under its "Blue Economy" initiatives to support the development of marine-derived pharmaceuticals.

On the nutraceutical front, the demand for marine omega-3 fatty acids, astaxanthin, and marine collagen is rising due to their health benefits. Regulatory bodies such as the European Food Safety Authority (EFSA) and the U.S. FDA have established frameworks that support the marketing of these marine-based functional ingredients.

Key Market Players

• Lonza Group
• Sea Run Holdings Inc
• PharmaMar S.A.
• Cyanotech Corporation
• New England Biolabs Inc.
• Qingdao Codo International Ltd
• Nutrex Hawai Inc.
• Royal DSM N.V.
• Prolume Ltd.
• CP Kelco US Inc.

Report Scope:

In this report, the Global Marine Biotechnology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Marine Biotechnology Market, By Type:

• Bioactive Substance
• Biomaterials

Marine Biotechnology Market, By Technology:

• Isolation and Cultivation of Microorganisms
• Culture-Independent Techniques

Marine Biotechnology Market, By Application:

• Aquaculture and Food Products
• Environment & Human Health
• Drug Discovery
• Others

Marine Biotechnology Market, By End User Industry:

• Biotechnology & Pharmaceuticals
• Chemicals
• Cosmetic
• Others

Marine Biotechnology Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Marine Biotechnology Market.

Available Customizations:

Global Marine Biotechnology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Marine Biotechnology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Bioactive Substance v/s Biomaterials)
  • 5.2.2. By Technology (Isolation and Cultivation of Microorganisms v/s Culture-Independent Techniques)
  • 5.2.3. By Application (Aquaculture and Food Products, Environment & Human Health, Drug Discovery, Others)
  • 5.2.4. By End User Industry (Biotechnology & Pharmaceuticals, Chemicals, Cosmetic, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Type
  • 5.3.2. By Technology
  • 5.3.3. By Application
  • 5.3.4. By End User Industry
  • 5.3.5. By Region

6. North America Marine Biotechnology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Application
  • 6.2.4. By End User Industry
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Marine Biotechnology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User Industry
  • 6.3.2. Canada Marine Biotechnology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User Industry
  • 6.3.3. Mexico Marine Biotechnology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User Industry

7. Europe Marine Biotechnology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Application
  • 7.2.4. By End User Industry
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Marine Biotechnology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User Industry
  • 7.3.2. Germany Marine Biotechnology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User Industry
  • 7.3.3. United Kingdom Marine Biotechnology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User Industry
  • 7.3.4. Italy Marine Biotechnology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User Industry
  • 7.3.5. Spain Marine Biotechnology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User Industry

8. Asia-Pacific Marine Biotechnology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Application
  • 8.2.4. By End User Industry
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Marine Biotechnology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User Industry
  • 8.3.2. India Marine Biotechnology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User Industry
  • 8.3.3. Japan Marine Biotechnology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User Industry
  • 8.3.4. South Korea Marine Biotechnology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User Industry
  • 8.3.5. Australia Marine Biotechnology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User Industry

9. South America Marine Biotechnology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Application
  • 9.2.4. By End User Industry
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Marine Biotechnology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User Industry
  • 9.3.2. Argentina Marine Biotechnology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User Industry
  • 9.3.3. Colombia Marine Biotechnology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User Industry

10. Middle East and Africa Marine Biotechnology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Application
  • 10.2.4. By End User Industry
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Marine Biotechnology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User Industry
  • 10.3.2. Saudi Arabia Marine Biotechnology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User Industry
  • 10.3.3. UAE Marine Biotechnology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User Industry

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Marine Biotechnology Market: SWOT Analysis

14. Porters Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products/Services

15. Competitive Landscape

• 15.1. Lonza Group
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Sea Run Holdings Inc
• 15.3. PharmaMar S.A.
• 15.4. Cyanotech Corporation
• 15.5. New England Biolabs Inc.
• 15.6. Qingdao Codo International Ltd
• 15.7. Nutrex Hawai Inc.
• 15.8. Royal DSM N.V.
• 15.9. Prolume Ltd.
• 15.10. CP Kelco US Inc.

16. Strategic Recommendations

17. About Us & Disclaimer